Machines learn to detect breast cancer
Key points
- Software that can recognize patterns in data is commonly used by scientists and economics.
- Duo Zhou a biostatistician at pharmaceutical company Pfizer in New York and colleagues Dinesh Mital and Shankar Srinivasan of the University of Medicine and Dentistry of New Jersey, point out that data pattern recognition is widely used in machine-learning applications in science.
- The team suggested that just such an automated statistical analysis methodology might readily be adapted to a clinical setting.
- The machine learning approach takes into account nine characteristics of a minimally invasive fine needle biopsy, including clump thickness, uniformity of cell size, adhesions, epithelial cell size, bare cell nuclei and other factors.
Software that can recognize patterns in data is commonly used by scientists and economics. Now, researchers in the US have applied similar algorithms to help them more accurately diagnose breast cancer. The researchers outline details in the International Journal of Medical Engineering and Informatics.
Duo Zhou a biostatistician at pharmaceutical company Pfizer in New York and colleagues Dinesh Mital and Shankar Srinivasan of the University of Medicine and Dentistry of New Jersey, point out that data pattern recognition is widely used in machine-learning applications in science. Computer algorithms trained on historical data can be used to analyze current information and detect patterns and then predict possible future patterns. However, this powerful knowledge discovery technology is little used in medicine.
The team suggested that just such an automated statistical analysis methodology might readily be adapted to a clinical setting. They have done just that in using an algorithmic approach to analyzing data from breast cancer screening to more precisely recognize the presence of malignant tumors in breast tissue as opposed to benign growths or calcium deposits. This could help improve outcomes for patients with malignancy but also reduce the number of false positives that otherwise lead patients to unnecessary therapeutic, chemotherapy or radiotherapy, and surgical interventions.
The machine learning approach takes into account nine characteristics of a minimally invasive fine needle biopsy, including clump thickness, uniformity of cell size, adhesions, epithelial cell size, bare cell nuclei and other factors. Trained on definitive data annotated as malignant or benign, the system was able to correlate the many disparate visual factors present in the data with the outcome. The statistical model thus developed could then be used to test new tissue samples for malignancy.
###
"Breast cancer diagnosis: a statistical analysis-based approach" in Int. J. Medical Engineering and Informatics, 2013, 5, 321-333
###
Albert Ang
press@inderscience.com
Inderscience Publishers
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsPortable breast scanner allows cancer detection in the blink of an eye
Professor Zhipeng Wu has invented a portable scanner based on radio frequency technology, which is able to show in a second the presence of tumours – malignant and benign – in the breast on a computer. Using radio…
28 October 2010
NewsUsing PET/CT in the Detection of Breast Cancer Metastases
About one-third of women diagnosed with early-stage breast cancer will have their cancer travel, or metastasize, to other parts of the body, with the bone being the most common site of initial detectable spread.…
7 September 2010
NewsObese women increased the risk of breast cancer and larger the tumor size when detected
Obese women should aware that they have not only the risk of breast cancer, but also more likely to have larger tumor when it detected at later stage. In abstract, the researchers said in their investigation, fewer…
